Clinical Trial Update: Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of melatonin in patients with severe sepsis or septic shock; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Aragon Institute of Health Sciences | Conditions: Severe Sepsis, Septic Shock | Phase 3 | Status: UNKNOWN